Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GANNON STEVEN Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 18,475 options to buy @ $38.96, valued at $719.8k
08/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2021 4 GANNON STEVEN (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Bought 6,000 shares @ $8.1, valued at $48.6k
06/07/2021 4 GANNON STEVEN (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 17,000 options to buy @ $8.15, valued at $138.6k
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2020 4 GANNON STEVEN (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.
Txns: Granted 141,011 options to buy @ $2.35, valued at $331.4k
Granted 30,000 options to buy @ $17, valued at $510k
06/25/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/02/2020 4 GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 10,000 options to buy @ $13.11, valued at $131.1k
09/18/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2018 4 GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 15,000 options to buy @ $6.2, valued at $93k
08/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2017 4 GANNON STEVEN (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.
Txns: Granted 3,500 options to buy @ $3.85, valued at $13.5k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy